Philip Morris International Inc. (VIE:PMOR)
Austria · Delayed Price · Currency is EUR | Market Cap | 257.72B +15.8% |
| Revenue (ttm) | 37.24B +8.9% |
| Net Income | 9.49B +32.1% |
| EPS | 6.08 +31.8% |
| Shares Out | n/a |
| PE Ratio | 27.15 |
| Forward PE | 22.11 |
| Dividend | 5.07 (3.07%) |
| Ex-Dividend Date | Jun 25, 2026 |
| Volume | n/a |
| Open | 165.90 |
| Previous Close | 167.72 |
| Day's Range | 164.50 - 165.90 |
| 52-Week Range | 124.64 - 179.00 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 21, 2026 |
About VIE:PMOR
Philip Morris International Inc. operates as a tobacco company. The company offers cigarettes and smoke-free products, including heat-not-burn, e-vapor, and oral nicotine products under the IQOS, VEEV, and ZYN brands; and consumer accessories, such as lighters and matches. It also offers wellness products. The company was incorporated in 1987 and is headquartered in Stamford, Connecticut. [Read more]
Financial Performance
In 2025, VIE:PMOR's revenue was $40.65 billion, an increase of 7.31% compared to the previous year's $37.88 billion. Earnings were $11.32 billion, an increase of 60.88%.
Financial numbers in USD Financial StatementsNews
Altria, Philip Morris International sign contract manufacturing deals
Philip Morris International and Altria said on Monday they had entered contract manufacturing arrangements with one another, as Altria looks to grow cigarette imports and exports and take advantage ...
Altria Announces Arrangement with Philip Morris International to Enhance Operational Efficiency
RICHMOND, Va.--(BUSINESS WIRE)--Altria Announces Arrangement with Philip Morris International to Enhance Operational Efficiency.
Philip Morris gets FDA nod for 11 new nicotine pouches
The U.S. Food and Drug Administration said on Friday it had authorized 11 nicotine pouch products recently launched by Philip Morris , citing lower levels of harmful constituents compared with other...
FDA Authorizes ZYN ULTRA Nicotine Pouches Following Scientific Review
STAMFORD, CT--(BUSINESS WIRE)--Philip Morris International Inc. (NYSE: PM) today announces that the U.S. Food and Drug Administration (FDA) issued Marketing Granted Orders to PMI's U.S. affiliate, Swe...
Can nicotine pouches drive Big Tobacco's future beyond cigarettes?
Fast-growing nicotine pouches have emerged as one of Big Tobacco's most important bets on a future beyond cigarettes, offering rapid growth, attractive margins and, for now, lighter regulation than ma...
Wolfe says buy these three quality stocks into post-earnings strength
July has dealt Wall Street a turbulent hand. US stocks have drifted lower this month, hampered by persistent geopolitical risks, rising crude oil prices, and mounting anxiety over rising AI capex.
ZYN growth EXPLODES as Philip Morris International expands US manufacturing
Philip Morris International U.S. CEO Stacey Kennedy discusses PMI's $1.2 billion investment in a new ZYN nicotine pouch manufacturing plant in Aurora, Colo., on 'The Claman Countdown.
Philip Morris Opens $1.2 Billion Manufacturing Campus to Grow Zyn Brand
Philip Morris International opened a $1.2 billion manufacturing campus in Colorado, part of the tobacco company's efforts to expand its Zyn portfolio and meet rising demand for nicotine pouches.
Philip Morris doubles Colorado campus investment to $1.2 billion
Philip Morris International said on Monday it had doubled its planned investment in its Colorado manufacturing campus to about $1.2 billion through 2028, as it expands production capacity for the Zy...
PMI U.S. Opens $1.2 Billion Aurora Campus, Strengthening U.S. Manufacturing and Export Capabilities
STAMFORD, CT--(BUSINESS WIRE)--Philip Morris International Inc.'s (PMI) (NYSE: PM) U.S. businesses (PMI U.S.) today celebrated the opening of its Aurora, Colorado manufacturing campus, a landmark inve...
Philip Morris International Earnings Call Transcript: Q2 2026
Q2 and H1 saw strong organic growth in revenue, operating income, and EPS, driven by smoke-free products and robust combustible performance. Guidance remains unchanged as increased U.S. investment is planned for H2, especially behind ZYN and IQOS ILUMA.
Philip Morris International Slides: Q2 2026
Philip Morris International has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 22, 2026.
Philip Morris International Earnings release: Q2 2026
Philip Morris International released its Q2 2026 earnings on July 22, 2026, summarizing the period's financial results.
Philip Morris International Quarterly report: Q2 2026
Philip Morris International has published its Q2 2026 quarterly earnings report on July 22, 2026.
Philip Morris Stock Falls After It Cuts Guidance, but There Is One Bright Spot
Philip Morris International reports better-than-expected second-quarter earnings but lowers full-year profit expectations.
Philip Morris Sales Boosted by Growth in International Business
Philip Morris International recorded higher revenue in the second quarter, boosted by growth in its international business and its Zyn portfolio in the U.S.
Philip Morris beats second-quarter sales estimates
Philip Morris beat Wall Street estimates for second-quarter sales on Wednesday, helped by strong demand for smoke-free products following recent regulatory approval for its Zyn nicotine pouche...
Philip Morris International Reports 2026 Second-Quarter & First Six-Months Results and Updates 2026 Full-Year Adjusted Diluted EPS Forecast for Currency Only;
STAMFORD, CT--(BUSINESS WIRE)--Regulatory News: Philip Morris International Inc. (PMI) (NYSE: PM) today announces its 2026 second quarter results.1 "We delivered outstanding results in the second quar...
Philip Morris International to Host Webcast of 2026 Second-Quarter and First Six-Months Results
STAMFORD, CT--(BUSINESS WIRE)--Regulatory News: Philip Morris International Inc. (PMI) (NYSE: PM) will host a live audio webcast on Wednesday, July 22, 2026, at 9:00 a.m. ET, to discuss its 2026 secon...
Investors flock to Big Tobacco as companies pivot to vapes and pouches — as moral taboo goes up in smoke
For nearly a decade, pension funds and major endowments blacklisted cigarette makers under strict sustainability mandates.
Tobacco Stocks Are Coming in From the Cold
Investors are taking a closer look at companies as they shift away from cigarettes.
Zyn can be marketed as safe alternative to cigarettes, FDA says
Federal regulator gives Philip Morris International a win for nicotine pouches.
FDA lets Philip Morris market Zyn nicotine pouches as less harmful than cigarettes
The FDA will allow 20 Philip Morris-owned Zyn nicotine pouch products to carry a modified-risk claim saying switching from cigarettes lowers the risk of several smoking-related diseases. The decision ...
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products
STAMFORD, CT--(BUSINESS WIRE)--Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for...
FDA allows Philip Morris to market Zyn as less harmful than cigarettes
The U.S. Food and Drug Administration said on Tuesday it would allow Philip Morris to market its Zyn nicotine pouches as less harmful than cigarettes.